Emergent Biosolutions
EBS
EBS
211 hedge funds and large institutions have $854M invested in Emergent Biosolutions in 2022 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 80 increasing their positions, 70 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
33% less capital invested
Capital invested by funds: $1.28B → $854M (-$424M)
38% less first-time investments, than exits
New positions opened: 29 | Existing positions closed: 47
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
211
Holding in Top 10
–
Calls
$1.78M
Puts
$2.01M
Top Buyers
| 1 | +$13.7M | |
| 2 | +$11.5M | |
| 3 | +$8.77M | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$7.99M |
| 5 |
Pacer Advisors
Malvern,
Pennsylvania
|
+$5.56M |
Top Sellers
| 1 | -$57.3M | |
| 2 | -$13.9M | |
| 3 | -$7.82M | |
| 4 |
Millennium Management
New York
|
-$7.27M |
| 5 |
New York State Common Retirement Fund
Albany,
New York
|
-$6.33M |